BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33909135)

  • 1. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry.
    Arndt AT; Brunelli A; Cicconi S; Falcoz PE; Salati M; Kozower B; Liptay MJ; Rocco G; Karush JM; Geissen N; Basu S; Seder CW
    Lung; 2021 Jun; 199(3):311-318. PubMed ID: 33909135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgically Managed Clinical Stage IIIA-Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database.
    Boffa D; Fernandez FG; Kim S; Kosinski A; Onaitis MW; Cowper P; Jacobs JP; Wright CD; Putnam JB; Furnary AP
    Ann Thorac Surg; 2017 Aug; 104(2):395-403. PubMed ID: 28527969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Pulmonary Resection Practices Between The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons General Thoracic Surgery Databases.
    Seder CW; Salati M; Kozower BD; Wright CD; Falcoz PE; Brunelli A; Fernandez FG
    Ann Thorac Surg; 2016 Jun; 101(6):2077-84. PubMed ID: 27021033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013.
    Dickhoff C; Dahele M; de Langen AJ; Paul MA; Smit EF; Senan S; Hartemink KJ; Damhuis RA
    J Thorac Oncol; 2016 Apr; 11(4):566-72. PubMed ID: 26773741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer.
    Broderick SR; Grau-Sepulveda M; Kosinski AS; Kurlansky PA; Shahian DM; Jacobs JP; Becker S; DeCamp MM; Seder CW; Grogan EL; Brown LM; Burfeind W; Magee M; Raymond DP; Puri V; Chang AC; Kozower BD
    Ann Thorac Surg; 2020 Mar; 109(3):848-855. PubMed ID: 31689407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
    Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
    Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes.
    Fernandez FG; Kosinski AS; Burfeind W; Park B; DeCamp MM; Seder C; Marshall B; Magee MJ; Wright CD; Kozower BD
    Ann Thorac Surg; 2016 Aug; 102(2):370-7. PubMed ID: 27209606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons General Thoracic Surgery Database for Lobectomy.
    Tong BC; Kim S; Kosinski A; Onaitis MW; Boffa DJ; Habib RH; Putnam JB; Furnary AP; Cowper P; Wright CD; Jacobs JP; Fernandez FG
    Ann Thorac Surg; 2019 Mar; 107(3):897-902. PubMed ID: 30253162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
    Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?
    Shah AA; Worni M; Kelsey CR; Onaitis MW; D'Amico TA; Berry MF
    Ann Thorac Surg; 2013 May; 95(5):1700-7. PubMed ID: 23545195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy with modern techniques does not improve survival for operable stage IIIA-N2 non-small cell lung cancer.
    Predina J; Suliman R; Potter AL; Panda N; Diao K; Lanuti M; Muniappan A; Jeffrey Yang CF
    J Thorac Cardiovasc Surg; 2023 May; 165(5):1696-1709.e4. PubMed ID: 36610886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
    Casiraghi M; Guarize J; Sandri A; Maisonneuve P; Brambilla D; Romano R; Galetta D; Petrella F; Gasparri R; Gridelli C; De Marinis F; Spaggiari L
    Clin Lung Cancer; 2019 Mar; 20(2):97-106.e1. PubMed ID: 30446406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality after induction chemotherapy followed by surgery in IIIa-N2 non small cell lung cancer.
    Borreman P; De Leyn P; Decaluwé H; Moons J; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Acta Chir Belg; 2009; 109(3):333-9. PubMed ID: 19943589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and long-term outcome of sleeve lobectomy for non-small cell lung cancer].
    Xie MR; Zhang X; Lin P; Chen JX; Ling YB; Fu JH; Rong TH; Zeng CG; Huang ZF
    Ai Zheng; 2009 Aug; 28(8):868-71. PubMed ID: 19664335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
    Zhong C; Yao F; Zhao H
    Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.